Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections

Oritavancin, a semisynthetic derivative of the glycopeptide antibiotic chloroeremomycin, received the US Food and Drug Administration approval for the treatment of acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria in adults in August 2014. This novel sec...

Full description

Saved in:
Bibliographic Details
Published in:Infect Drug Resist
Main Authors: Mitra, Subhashis, Saeed, Usman, Havlichek, Daniel H, Stein, Gary E
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2015
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4500617/
https://ncbi.nlm.nih.gov/pubmed/26185459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S69412
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items